The Immunoglobulin genes and Chronic Lymphocytic Leukemia (CLL)

References

• Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994;8:1640–1645.
   PubMed Web of Science ®Google Scholar
• Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46:219–234.
   PubMed Web of Science ®Google Scholar
• Binet JL, Lepoprier M, Dighiero G, et al. A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer. 1977;40:855–864.
   PubMed Web of Science ®Google Scholar
• Dohner H, Stilgenbauer S. Benner A, et al. Genomic aberrations and survival in chronic lympho-cytic leukemia. N Engl J Med. 2000;343:1910–1916.
   PubMed Web of Science ®Google Scholar
• Hamblin TJ, Davis Z, Gardiner A, et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848–1854.
   PubMed Web of Science ®Google Scholar
• Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prog-nostic indicators in chronic lymphocytic leukemia. Blood. 199994:1840-1847.
   PubMed Web of Science ®Google Scholar
• Maloum K, Davi F, Merle-Beral H, et al. Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia. Blood. 2000;96:377–379.
   Google Scholar
• Thunberg U, Johnson A, Roos G, et al. CD38 expression is a poor predictor for VH gene muta-tional status and prognosis in chronic lymphocytic leukemia. Blood. 200197:1892-1894.
   PubMed Web of Science ®Google Scholar
• Cook GP, Tomlinson IM. The human immunoglobulin VH repertoire. Immunol Today. 1995;16:237–242.
   PubMedGoogle Scholar
• Lefranc M-P. Locus maps and genomic repertoire of the human Ig genes. The Immunologist. Vol. 8; 2000:80–87.
   Google Scholar
• Lefranc M-P, Lefranc G. The immunoglobulin Factsbook: Academic Press,Hartcourt Publishers Limited,London; 2001.
   Google Scholar
• Kitamura D, Kudo A, Schaal S, et al. A critical role of lambda 5 protein in B cell development. Cell. 1992;69:823–831.
   PubMed Web of Science ®Google Scholar
• Korsmeyer SJ, Hieter PA, Sharrow SO, et al. Normal human B cells display ordered light chain gene rearrangements and deletions. J Exp Med. 1982;156:975–985.
   PubMed Web of Science ®Google Scholar
• Brauninger A, Goossens T, Rajewsky K, et al. Regulation of immunoglobulin light chain gene rearrangements during early B cell development in the human. Eur J Immunol. 2001; 31: 3631–3637.
   PubMed Web of Science ®Google Scholar
• Goldsby RA, Kuby J. Immunology (ed 5.). New York: W.H. Freeman; 2003.
   Google Scholar
• Kelsoe G. The germinal center: a crucible for lymphocyte selection. Seminars in Immunology. 1996;8:179–184.
   PubMedGoogle Scholar
• Berek C, Kim HJ. B-cell activation and development within chronically inflamed synovium in rheumatoid and reactive arthritis. Semin Immunol. 1997;9:261–268.
   PubMedGoogle Scholar
• Voigt I, Camacho SA, de Boer BA, et al. CXCR5-deficient mice develop functional germinal cen-ters in the splenic T cell zone. Eur J Immunol. 2000;30:560–567.
   PubMed Web of Science ®Google Scholar
• Rajewsky K, Forster I, Cumano A. Evolutionary and somatic selection of the antibody repertoire in the mouse. Science. 1987;238:1088–1094.
   Google Scholar
• Domer T, Foster SJ, Famer NIL, et al. Somatic hypermutation of human immunoglobulin heavy chain genes: targeting of RGYVV motifs on both DNA strands. Eur J Immunol. 1998; 28: 3384–3396.
   PubMed Web of Science ®Google Scholar
• Rogozin D3, Diaz M. Cutting Edge: DGYVV/VVRCH Is a Better Predictor of Mutability at G:C Bases in Ig Hypermutation Than the Widely Accepted RGYW/VVRCY Motif and Probably Reflects a Two-Step Activation-Induced Cytidine Deaminase-Triggered Process. J Immunol. 2004;172: 3382–3384.
   Google Scholar
• Xu JL, Davis MM. Diversity in the CDR3 region of V(H) is sufficient for most antibody specifici-ties. Immunity. 2000;13:37–45.
   PubMed Web of Science ®Google Scholar
• Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med. 1998;188: 1679–1689.
   Google Scholar
• Kuppers R, Klein U, Hansmann M-L, et al. Cellular Origin of Human B-Cell Lymphomas. N Engl J Med. 1999;341:1520–1529.
   PubMed Web of Science ®Google Scholar
• Matsuda F, Shin EK, Nagaoka H, et al. Structure and physical map of 64 variable segments in the 3'0.8-megabase region of the human immunoglobulin heavy-chain locus. Nat Genet. 1993;3:88–94.
   Google Scholar
• Thorselius M, Walsh S, Eriksson I, et al. Somatic hypermutation and V(H) gene usage in mantle cell lymphoma. Eur J Haematol. 2002;68:217–224.
   PubMed Web of Science ®Google Scholar
• Rettig MB, Vescio RA, Cao J, et al. VH gene usage is multiple myeloma: complete absence of the VH4.21 (VH4-34) gene. Blood. 1996;87:2846–2852.
   Google Scholar
• Cleary ML, Meeker TC, Levy S, et al. Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell. 1986;44:97–106.
   PubMed Web of Science ®Google Scholar
• Bahler DW, Campbell MJ, Hart S, et al. Ig VH gene expression among human follicular lym-phomas. Blood. 1991;78:1561–1568.
   PubMed Web of Science ®Google Scholar
• Zhu D, Hawkins RE, Hamblin TJ, et al. Clonal history of a human follicular lymphoma as revealed in the immunoglobulin variable region genes. Br J Haematol. 1994;86:505–512.
   PubMed Web of Science ®Google Scholar
• Kuppers R, Rajewsky K, Hansmann ML. Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression. Eur J Immunol. 1997;27:1398–1405.
   Google Scholar
• Ottensmeier CH, Thompsett AR, Zhu D, et al. Analysis of VH genes in follicular and diffuse lym-phoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood. 1998;91:4292–4299.
   PubMed Web of Science ®Google Scholar
• Lossos IS, Alizadeh AA, Eisen MB, et al. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci US A. 2000;97:10209–10213.
   PubMed Web of Science ®Google Scholar
• Klein U, Klein G, Ehlin-Henriksson B, et al. Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes. Mol Med. 1995;1:495–505.
   Google Scholar
• Tamaru J, Hummel M, Marafioti T, et al. Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations. Am J Pathol. 1995;147:1398–1407.
   PubMed Web of Science ®Google Scholar
• Tierens A, Delabie J, Malecka A, et al. Splenic marginal zone lymphoma with villous lympho-cytes shows on-going immunoglobulin gene mutations. Am J Pathol. 2003;162:681–689.
   PubMed Web of Science ®Google Scholar
• Bakkus MH, Heirman C, Van Riet I, et al. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood. 1992;80:2326–2335.
   PubMed Web of Science ®Google Scholar
• Kipps TJ, Tomhave E, Pratt LF, et al. Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 1989;86:5913–5917.
   PubMed Web of Science ®Google Scholar
• Deane M, Norton JD. Preferential rearrangement of developmentally regulated immunoglobulin VH1 genes in human B-lineage leukaemias. Leukemia. 1991;5:646–650.
   PubMed Web of Science ®Google Scholar
• Ebeling SB, Schutte ME, Akkermans-Koolhaas KE, et al. Expression of members of the immunoglobulin VH3 gene families is not restricted at the level of individual genes in human chronic lymphocytic leukemia. Int Immunol. 1992;4: 313–320.
   Google Scholar
• Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102:1515–1525.
   PubMed Web of Science ®Google Scholar
• Schroeder HVV, Jr., Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire [see comments]. Immunol Today. 1994;15:288–294.
   Google Scholar
• Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001; 194:1625–1638.
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194:1639–1647.
   PubMed Web of Science ®Google Scholar
• Damle RN, Ghiotto F, Valetto A, et al. B-cell chronic lymphocytic leukemia cells express a sur-face membrane phenotype of activated, antigen-experienced B lymphocytes. Blood. 2002; 99: 4087–4093.
   PubMed Web of Science ®Google Scholar
• Vilpo J, Tobin G, Hullckonen J, et al. Surface antigen expression and correlation with variable heavy-chain gene mutation status in chronic lymphocytic leukemia. Eur J Haematol. 2003:53–59.
   PubMed Web of Science ®Google Scholar
• Dunn-Walters D, Isaacson P, Spencer J. Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J. Exp. Med. 1995;182:559–566.
   Google Scholar
• Dunn-Walters DK, Isaacson PG, Spencer J. Sequence analysis of rearranged IgVH genes from microdissected human Peyer's patch marginal zone B cells. Immunology. 1996;88:618–624.
   Google Scholar
• Tierens A, Delabie J, Michiels L, et al. Marginal-Zone B Cells in the Human Lymph Node and Spleen Show Somatic Hypermutations and Display Clonal Expansion. Blood. 1999;93:226–234.
   PubMed Web of Science ®Google Scholar
• Chiorazzi N, Ferrarini M. B CELL CHRONIC LYMPHOCYTIC LEUKEMIA: Lessons Learned from Studies of the B Cell Antigen Receptor. Annu Rev Immunol. 2003;21:841–894.
   PubMed Web of Science ®Google Scholar
• Messmer BT, Albesiano E, Messmer D, et al. The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process. Blood. 2004;103:3490–3495.
   PubMed Web of Science ®Google Scholar
• van Esch WJ, Reparon-Schuijt CC, Hamstra HJ, et al. Polyreactivity of Human IgG Fc-binding Phage Antibodies Constructed from Synovial Fluid CD38+ B Cells of Patients with Rheumatoid Arthritis. J Autoimmun. 2002;19:241–250.
   PubMed Web of Science ®Google Scholar
• Walsh SH, Thorselius M, Johnson A, et al. Mutated VH genes and preferential VH3-21 usage define new subsets of mantle cell lymphoma. Blood. 2003.
   Google Scholar
• Marasca R, Vaccari P. Luppi M, et al. Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal mar-ginal zone B-cell lymphoma. Am J Pathol. 2001;159:253–261.
   PubMed Web of Science ®Google Scholar
• Oscier DG, Thompsett A, Zhu D, et al. Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood. 1997;89:4153–4160.
   PubMed Web of Science ®Google Scholar
• Rosenquist R, Lindstrom A, Holmberg D, et al. V(H) gene family utilization in different B-cell lymphoma subgroups. Eur J Haematol. 1999;62:123–128.
   PubMed Web of Science ®Google Scholar
• Miklos JA, Swerdlow SH, Bahler DW. Salivary gland mucosa-associated lymphoid tissue lym-phoma immunoglobulin V(H) genes show frequent use of V1-69 with distinctive CDR3 features. Blood. 2000;95: 3878–3884.
   Google Scholar
• Borretzen M, Chapman C, Stevenson FK, et al. Structural analysis of VH4-21 encoded human IgM allo- and autoantibodies against red blood cells. Scand J Immunol. 1995;42:90–97.
   PubMed Web of Science ®Google Scholar
• Silberstein LE, George A, Durdik .TM, et al. The V4-34 Encoded Anti-i Autoantibodies Recognize a Large Subset of Human and Mouse B-Cells*l. Blood Cells, Molecules, and Diseases. 1996;22: 126–138.
   Google Scholar
• Elagib KE, Tengner P, Levi M, et al. Immunoglobulin variable genes and epitope recognition of human monoclonal anti-Ro 52-kd in primary Sjogren's syndrome. Arthritis Rheum. 1999; 42: 2471–2481.
   PubMed Web of Science ®Google Scholar
• Bhat, Bieber, Spellerberg, et al. Recognition of Auto- and Exoantigens by V4-34 Gene Encoded Antibodies. Scand J Immunol. 2000;51:134–140.
   PubMed Web of Science ®Google Scholar
• Cappione AJ, Pugh-Bernard AE, Anolik JH, et al. Lupus IgG V(H)4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes. J Immunol. 2004; 172: 4298–4307.
   Google Scholar
• Johnson TA, Rassenti LZ, Kipps TJ. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol. 1997;158: 235–246.
   Google Scholar
• Potter KN, Orchard J, Critchley E, et al. Features of the overexpressed V1-69 genes in the unmu-tated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly reper-toire. Blood. 2003;101:3082–3084.
   PubMed Web of Science ®Google Scholar
• Hickman SE, el Khoury J, Greenberg S, et al. P2Z adenosine triphosphate receptor activity in cul-tured human monocyte-derived macrophages. Blood. 1994;84:2452–2456.
   PubMed Web of Science ®Google Scholar
• Di Virgilio F. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol Today. 1995;16:524–528.
   PubMedGoogle Scholar
• Surprenant A, Rassendren F, Kawashima E, et al. The Cytolytic P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7). Science. 1996;272:735–738.
   PubMed Web of Science ®Google Scholar
• Baricordi OR, Ferrari D, Melchiorri L, et al. An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood. 1996;87:682–690.
   PubMed Web of Science ®Google Scholar
• Adinolfi E, Melchiorri L, Falzoni S, et al. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood. 2002;99:706–708.
   PubMed Web of Science ®Google Scholar
• Wiley JS, Dao-Ung LP, Gu BJ, et al. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet. 2002; 359: 1114–1119.
   PubMed Web of Science ®Google Scholar
• Gu BJ, Zhang W, Worthington RA, et al. A Glu-496 to Ala Polymorphism Leads to Loss of Func-tion of the Human P2X7 Receptor. J. Biol. Chem. 2001;276:11135–11142.
   PubMed Web of Science ®Google Scholar
• Tobin G, Thunberg U, Johnson A, et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood. 2002;99:2262–2264.
   PubMed Web of Science ®Google Scholar
• Tobin G, Thunberg U, Johnson A, et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recog-nition of a common antigen epitope. Blood. 2003;101:4952–4957.
   PubMed Web of Science ®Google Scholar
• He X, Goronzy JJ, Thong W, et al. VH3-21 B cells escape from a state of tolerance in rheumatoid arthritis and secrete rheumatoid factor. Mol Med. 1995;1:768–780.
   PubMed Web of Science ®Google Scholar
• Sasaki M, Van De Water J, Kenny TP, et al. Immunoglobulin gene usage and immunohistochemi-cal characteristics of human monoclonal antibodies to the mitochondrial autoantigens of primary biliary cirrhosis induced in the XenoMouse. Hepatology. 2001;34:631–637.
   PubMed Web of Science ®Google Scholar
• Krober A, Benner A, Baler A, et al. Multivariate Survival Analysis of Specific VH-Genes in CLL: V3-21 and V3-23 Are Prognostic Factors Independently of the VH Mutation Status. ASH. 2002;100:196a.
   Google Scholar
• Van Es JH, Aanstoot H, Gmelig-Meyling FH, et al. A human systemic lupus erythematosus-relat-ed anti-cardiolipin/single-stranded DNA autoantibody is encoded by a somatically mutated variant of the developmentally restricted 51P1 VH gene. J Immunol. 1992;149: 2234–2240.
   Google Scholar
• Martin T, Crouzier R, Weber JC, et al. Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third comple-mentarity-determining region of the antibody heavy chain. J Immunol. 1994;152:5988–5996.
   Google Scholar
• Tobin G, Thunberg U, Karlsson K, et al. Subsets with restricted immunoglobulin gene rearrange-ment features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood. 2004.
   Google Scholar
• Brezinschek HP, Foster SJ, Brezinschek RI, et al. Analysis of the human VH gene repertoire. Dif-ferential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. J Chin Invest. 1997;99:2488–2501.
   Google Scholar
• Geiger KD, Klein U, Brauninger A, et al. CD5-positive B cells in healthy elderly humans are a polyclonal B cell population. Eur J Immunol. 2000;30:2918–2923.
   PubMed Web of Science ®Google Scholar
• Kolar GR, Capra JD. Ig V region restrictions in human chronic lymphocytic leukemia suggest some cases have a common origin. J Chin Invest. 2004;113:952–954.
   PubMed Web of Science ®Google Scholar
• Valetto A, Ghiotto F, Fais F, et al. A subset of IgG+ B-CLL cells expresses virtually identical antigen receptors that bind similar peptides. Blood. 1998;92:A431.
   Web of Science ®Google Scholar
• Ghiotto F, Fais F, Valetto A, et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Chin Invest. 2004;113:1008–1016.
   PubMed Web of Science ®Google Scholar
• Martin T, Duffy SF, Carson DA, et al. Evidence for somatic selection of natural autoantibodies. J Exp Med. 1992;175:983–991.
   PubMed Web of Science ®Google Scholar
• Lanham S, Hamblin T, Oscier D, et al. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood. 2003; 101:1087–1093.
   PubMed Web of Science ®Google Scholar
• Tobin G, Thunberg U, Laurell A, et al. VH gene mutation analysis distinguishes a subgroup of chron-ic lymphocytic leukemia with low-mutated VH genes and inferior outcome. Submitted. 2004.
   Google Scholar
• Oscier DG, Gardiner AC, Mould SJ, et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood. 2002;100:1177–1184.
   PubMed Web of Science ®Google Scholar
• Matrai Z, Lin K, Dennis M, et al. CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia. Blood. 200197:1902-1903.
   PubMed Web of Science ®Google Scholar
• Jelinek DF, Tschumper RC, Geyer SM, et al. Analysis of clonal B-cell CD38 and immunoglobu-lin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Br J Haematol. 2001;115:854–861.
   PubMed Web of Science ®Google Scholar
• Krober A, Seiler T, Benner A, et al. V(H) mutation status, CD38 expression level, genomic aber-rations, and survival in chronic lymphocytic leukemia. Blood. 2002;100:1410–1416.
   PubMed Web of Science ®Google Scholar
• Lin K, Sherrington PD, Dennis M, et al. Relationship between p53 dysfunction, CD38 expres-sion, and IgV(H) mutation in chronic lymphocytic leukemia. Blood. 2002;100:1404–1409.
   PubMed Web of Science ®Google Scholar
• Crespo M, Bosch F, Villamor N, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med. 2003; 348: 1764-1775.
   Google Scholar
• Orchard JA, Ibbotson RE, Davis Z, et al. ZAP-70 expression and prognosis in chronic lympho-cytic leukaemia. Lancet. 2004;363:105–111.
   PubMed Web of Science ®Google Scholar
• Pittner BT, Tschumper RC, Kimlinger TK, et al. Expression of ZAP-70 in Both Unmutated and Mutated Leukemic CLL B Cells Indicates Lack of Efficacy as a Surrogate Marker for Immunoglobulin Mutational Status. Blood. 2003;102:ASH abstract 109.
   Google Scholar
• 0 Connor SM, Starczynski J, Teasdale J, et al. Can Zap-70 Protein Expression in B-CLL as Dec-tected by Immunohistochemistry Predict VH Mutation Status? Blood. 2003;102:ASH abstract 108.
   Google Scholar
• Hultdin M, Rosenquist R, Thunberg U, et al. Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications. Br J Cancer. 2003;88:593–598.
   PubMed Web of Science ®Google Scholar
• Thunberg U, Tobin G, Johnson A, et al. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet. 2002360:1935-1939.
   Web of Science ®Google Scholar
• Caligaris-Cappio F. Role of the microenvironment in chronic lymphocytic leukaemia. Br J Haematol. 2003;123:380–388.
   PubMed Web of Science ®Google Scholar
• Nuckel H, Frey UH, Dung J, et al. 1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome. Eur J Haematol. 2004; 72: 259–263.
   PubMed Web of Science ®Google Scholar
• Starczynski J, Pepper C, Pratt G, et al. The P2X7 receptor gene polymorphism 1513 A->C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bc1-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia. Br J Haematol. 2003;123:66–71.
   PubMed Web of Science ®Google Scholar
• Zhang LY, Ibbotson RE, Orchard JA, et al. P2X7 polymorphism and chronic lymphocytic leukaemia: lack of correlation with incidence, survival and abnormalities of chromosome 12. Leukemia. 2003;17:2097–2100.
   PubMed Web of Science ®Google Scholar